Valuation: Takeda Pharmaceutical Company Limited

Market Cap 9,105B 57.04B 49.27B 46.35B 42.13B 79.24B 5,465B 80.4B 544B 213B 2,733B 214B 210B P/E 2027 *
46.5x
P/E 2028 * 29.7x
Enterprise Value 13,007B 81.49B 70.38B 66.22B 60.18B 113B 7,808B 115B 777B 304B 3,905B 306B 299B EV / Sales 2027 *
2.78x
EV / Sales 2028 * 2.69x
Free-Float
99.28%
Yield 2027 *
3.58%
Yield 2028 * 3.65%
1 day+1.18%
1 week+3.72%
Current month+4.64%
1 month+3.85%
3 months+9.91%
6 months-0.69%
Current year+19.32%
1 week 5,482
Extreme 5482
5,815
1 month 5,225
Extreme 5225
5,903
Current year 4,710
Extreme 4710
6,033
1 year 4,102
Extreme 4102
6,033
3 years 3,852
Extreme 3852
6,033
5 years 2,993
Extreme 2993
6,033
10 years 2,894.5
Extreme 2894.5
6,693
Manager TitleAgeSince
Chief Executive Officer 56 2024-12-31
Director of Finance/CFO 48 2024-03-31
Chief Tech/Sci/R&D Officer 47 2022-01-31
Director TitleAgeSince
Director/Board Member 60 2015-05-31
Director/Board Member 73 2018-12-31
Director/Board Member 48 2024-05-31
Date Insider Type Main position Quantity % Market Cap.
8/11/26 Sell

Pres., Global Supply & Quality

-20,363 0.0013%
8/10/26 Sell

Pres., Global Supply & Quality

-3,978 0.0002%
8/10/26 Sell

Chief Executive Officer

-89,090 0.0056%
Change 5-day change 1-year change 3-year change Capi.($)
+1.02%+3.72%+28.60%+31.35% 55.24B
+3.60%+0.88%+75.59%+124.32% 1,055B
+3.33%+4.35%+53.82%+57.17% 632B
+3.43%+3.53%+25.34%+72.45% 442B
+1.35%-3.27%+40.98%+39.91% 351B
+1.75%-0.98%+26.20%+39.73% 290B
+2.13%-1.53%+1.85%+9.40% 243B
+1.41%+2.65%+45.34%+62.43% 227B
+1.35%-3.20%-9.07%-53.51% 200B
+3.25%+5.65%+21.57%+89.04% 172B
Average +2.28%-0.70%+31.02%+47.23% 366.78B
Weighted average by Cap. +2.76%-0.20%+43.94%+67.51%

Financials

2027 *2028 *
Net sales 4,684B 29.34B 25.34B 23.85B 21.67B 40.76B 2,811B 41.36B 280B 110B 1,406B 110B 108B 4,758B 29.81B 25.75B 24.23B 22.02B 41.41B 2,856B 42.02B 284B 111B 1,429B 112B 109B
Net income 191B 1.19B 1.03B 971M 882M 1.66B 114B 1.68B 11.39B 4.46B 57.24B 4.49B 4.39B 313B 1.96B 1.69B 1.59B 1.45B 2.72B 188B 2.76B 18.69B 7.33B 93.98B 7.36B 7.2B
Net Debt 3,902B 24.45B 21.12B 19.87B 18.06B 33.96B 2,342B 34.46B 233B 91.33B 1,172B 91.79B 89.8B 3,701B 23.19B 20.03B 18.84B 17.13B 32.21B 2,222B 32.68B 221B 86.62B 1,111B 87.06B 85.17B
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Employees
47,029
Date Price Change Volume
26-08-18 JP¥5,712.00 +0.18% 2,623,300
26-08-18 JP¥5,702.00 +3.43% 4,655,200
26-08-17 JP¥5,513.00 -1.75% 2,529,900
26-08-14 JP¥5,611.00 +0.94% 4,376,500
26-08-13 JP¥5,559.00 -0.05% 2,954,100
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
5,702.00JPY
Average target price
6,450.19JPY
Spread / Average Target
+13.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4502 Stock